- Extreme lateral interbody fusion (XLIF) surgery is a minimally invasive spinal procedure that allows access to the intervertebral disc space via the patient’s side, reducing tissue disruption and recovery time
- The demand for XLIF procedures is primarily driven by the rising prevalence of degenerative disc diseases and the growing preference for minimally invasive spinal surgeries
- North America is expected to dominate the extreme lateral interbody fusion (XLIF) Surgery market with a market share of 54.8%, due to its advanced healthcare infrastructure, high adoption of minimally invasive surgical techniques, and strong presence of key market players
- Asia-Pacific is expected to be the fastest growing region in the extreme lateral interbody fusion (XLIF) Surgery market with a market share of 12.7%, during the forecast period due to rapid improvements in healthcare infrastructure, increasing awareness about spinal health, and a rising volume of spinal surgeries
- XLIF interbody fusion systems segment is expected to dominate the market with a market share of 60.5% due to its comprehensive approach to spinal stabilization and reduced surgical complications
